No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.0x · 10Y median 0.5x · 91st percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:20:51.290Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Aveanna Healthcare Holdings Inc. (AVAH) stock was $12.37 as of Oct 5, 2026, 4:00 PM EDT, down 1.75% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +43.1% · 3-year avg +121.3%/yr · 5-year avg +9.8%/yr
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States.
Medical - Care Facilities · Atlanta, GA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.21
Revenue Est.
$679.51M
Last Quarter Results
EPS
$0.22
vs Estimate
$0.17
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AVAH | $2.69B | $12.37 | -1.75% | +43.09% | +9.75% | N/A | N/A |
| 2ACHC | $2.69B | $28.87 | +2.89% | +6.34% | -13.91% | -5.09% | vs AVAH |
| 3ALMR | $2.64B | $38.13 | +10.97% | N/A | N/A | N/A | vs AVAH |
| 4BEAM | $2.64B | $25.67 | +4.78% | -0.31% | -21.41% | N/A | vs AVAH |
| 5ATRC | $2.87B | $56.37 | +2.23% | +61.56% | -4.06% | +13.44% | vs AVAH |
| 6TMDX | $2.87B | $82.99 | +4.00% | -28.15% | +21.77% | N/A | vs AVAH |
9.38
$670.48M
vs Estimate
$638.61M
Consensus Rating
Based on 10 analysts
Average Price Target
$14.60
+18.0% upside
Low
$13.00
Current
$12.37
High
$16.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.20 | $0.21 | $0.22 | 6 |
| Quarter ending Jan 2027 | $0.21 | $0.21 | $0.22 | 6 |
| Quarter ending Apr 2027 | $0.21 | $0.21 | $0.21 | 2 |
| Quarter ending Jul 2027 | $0.23 | $0.23 | $0.24 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.82 | $0.82 | $0.83 | 6 |
| FY 2028 | $0.90 | $0.91 | $0.93 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $674.57M | $679.51M | $683.86M | 6 |
| Quarter ending Jan 2027 | $693.61M | $695.57M | $696.91M | 6 |
| Quarter ending Apr 2027 | $708.15M | $713.60M | $724.93M | 3 |
| Quarter ending Jul 2027 | $724.38M | $729.96M | $741.55M | 3 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Jan 3, 2027, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $2.67B | $2.69B | $2.70B | 8 |
| FY 2028 | $2.89B | $2.90B | $2.93B | 8 |
